BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2223644)

  • 21. Haemopoietic growth factors, the cell cycle of acute myeloblastic leukaemia progenitors and sensitivity to cytosine arabinoside.
    Smith MA; Smith JG; Pallister CJ; Singer CR
    Leuk Lymphoma; 1996 Nov; 23(5-6):467-72. PubMed ID: 9031077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of rh-cytokines on the sensitivity of normal human CFU-GM progenitors to Ara-C and on the S-phase activity of light density human bone marrow cells.
    Smith MA; Smith JG; Provan AB; Singer CR
    Leuk Res; 1994 Feb; 18(2):105-10. PubMed ID: 7509013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of interleukin-3 on the proliferation of leukaemic progenitor cells from patients with acute myeloblastic leukaemia.
    Asano Y; Shibata S; Kobayashi S; Okamura S; Akazawa K; Niho Y
    Clin Lab Haematol; 1998 Aug; 20(4):225-9. PubMed ID: 9777269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
    Jahns-Streubel G; Reuter C; Unterhalt M; Schleyer E; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1995 Nov; 9(11):1857-63. PubMed ID: 7475275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activity of various hematopoietic growth factors on acute myeloblastic leukemia blasts].
    Almeida J; del Cañizo MC; Vidriales B; Hernández MD; Galende J; San Miguel J
    Sangre (Barc); 1996 Feb; 41(1):3-8. PubMed ID: 8779032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic cytotoxicity of cytosine arabinoside and mitoxantrone for K562 and CFU-GM.
    Krehmeier C; Zühlsdorf M; Büchner T; Hiddemann W
    Haematol Blood Transfus; 1990; 33():129-32. PubMed ID: 2323625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
    Nara N
    Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S; Traylor R; Bhalla K; McCrady C; Pettit GR
    Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells.
    Carlo-Stella C; Regazzi E; Garau D; Mangoni L; Rizzo MT; Bonati A; Dotti G; Almici C; Rizzoli V
    Br J Haematol; 1996 Jun; 93(3):551-7. PubMed ID: 8652372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of the cytotoxicity of cytosine arabinoside by interleukin-3.
    Tanaka M
    Jpn J Cancer Res; 1992 Feb; 83(2):194-9. PubMed ID: 1556000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cells.
    Muus P; Haanen C; Raijmakers R; de Witte T; Salden M; Wessels J
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):238-44. PubMed ID: 3473679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effects of interleukin-11 with other growth factors on the expansion of hematopoietic progenitors from normal individuals and chronic myeloid leukemia patients resistant to treatment with cytosine arabinoside or eilatin.
    Einat M; Nagler A; Amiel A; Fejgin MD; Rudi A; Kashman Y; Fabian I
    Leuk Res; 1996 Sep; 20(9):751-9. PubMed ID: 8947585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies.
    Curtis JE; Minkin S; Minden MD; McCulloch EA
    Br J Haematol; 1996 Nov; 95(2):354-63. PubMed ID: 8904892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of busulfan, cytosine arabinoside and adriamycin on different maturation stages of normal human bone marrow cells.
    Tohda S; Nagata K; Suzuki T; Nara N
    Acta Haematol; 1990; 83(1):16-21. PubMed ID: 2105564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro].
    Wächter M; Goldschmidt H; Blau W; Elstner E; Ihle R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):927-34. PubMed ID: 2467864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
    Bhalla K; Birkhofer M; Arlin Z; Grant S; Lutzky J; Graham G
    Leukemia; 1988 Dec; 2(12):810-3. PubMed ID: 3264363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.